Durable remission achieved in pediatric patients with TCF3-HLF-positive relapsed/refractory B-cell acute lymphoblastic leukemia by dual CD19- and CD22-targeted chimeric antigen receptor T-cell therapy
通过双重靶向CD19和CD22的嵌合抗原受体T细胞疗法,TCF3-HLF阳性复发/难治性B细胞急性淋巴细胞白血病患儿实现了持久缓解
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.287023
Wan, Xinyu; Wang, Tianyi; Yang, Jing; Yang, Xiaomin; Li, Wenjie; Ding, Lixia; Yang, Liu; Zhang, Jing; Su, Meng; An, Kang; Zhou, Zicha; Li, Yue; Wang, Xiang; Zhu, Hua; Luo, Chengjuan; Gu, Longjun; Chen, Jing; Song, Lili; Tang, Yanjing; Li, Benshang
B细胞
T细胞
信号转导
白血病
CD22
T细胞
细胞生物学
CD2
CD19
免疫/内分泌